Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jan 30;8(7):1760–1771. doi: 10.1182/bloodadvances.2023011869

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure 1. — The flow chart of selecting patients with AML for this study and their composition based on WHO-HAEM5 and ICC classifications. (A) The flowchart outlining the eligibility criteria for the study. (B) The overlapping cases between the WHO and ICC classifications, demonstrating the flow of the study cohort within the 2 classifications. ∗APL with PML::RARA (4), AML with RUNX1::RUNX1T1 fusion (8), AML with CBFB::MYH11 fusion (17), AML with DEK::NUM214 fusion (2), AML with KMT2A rearrangement (16), AML with MECOM rearrangement (13), AML with NPM1 mutation (150), AML with CEBPA mutation (21), AML with BCR::ABL1 fusion (3), AML with other defined alterations (3).